- All > Medicine Information and Evidence for Policy > Medicines Policy
- All > Medicine Programme Coordination > Programme Coordination
- Keywords > access to affordable essential medicines
- Keywords > affordable prices
- Keywords > availability, affordability, and quality of pharmaceutical products
- Keywords > EC/ACP/WHO partnership program
- Keywords > health system strengthening
- Keywords > pharmaceutical services - building capacity
- Keywords > policy perspectives
- Keywords > strategies
- Keywords > Strengthening Pharmaceutical Systems (SPS)
- Keywords > universal health coverage (UHC)
(2016; 24 pages)
The EU/ACP/WHO Renewed Partnership to strengthen pharmaceutical systems and improve access to quality medicines began in 2012, and focuses on the implementation of policies, enforcement of regulations, adoption of best practices and on the promotion of policy dialogue and strengthening of pharmaceutical sector capacity. It aims to contribute to the achievement of health-related Millennium Development Goals and universal health coverage by improving the availability, affordability and use of safe, effective and quality assured essential medicines for priority communicable and non-communicable diseases. Ministries of Health lead the implementation in countries. WHO is responsible for coordinating overall planning, implementation and monitoring.
The programme is primarily funded by the European Commission.